June 28, 2011 (San Diego) -- The experimental drug teplizumab shows promise for delaying the progression of type 1 diabetes in people newly diagnosed with it, researchers say.
In a study of 513 patients with type 1 diabetes, the drug failed to reach its primary goal of substantially improving blood sugar control and reducing the amount of insulin needed.
But teplizumab appeared to preserve the function of the body's own insulin-producing beta cells in the pancreas, reports Nicole Sherry, MD, director of the diabetes center at the Massachusetts General Hospital for Children in Boston.
"Preserving your own beta cell function is far better than relying on insulin [injections or a pump]," says Kevan Herold, MD, a Yale University endocrinologist who is heading another study of teplizumab.
"Beta cells make the right amount of insulin at the right place and the right time," he tells WebMD. "They turn it off when you don't need it, and turn it on when you do need it."
Sherry and Herold reporting being consultants to MacroGenics, which is developing teplizumab.
The findings were simultaneously reported online in The Lancet and here at the American Diabetes Association meeting.
Type 1 diabetes is a disease in which the body's immune system attacks and destroys the insulin-producing beta cells of the pancreas.
The study involved people ages 8 to 35 who were diagnosed with type 1 diabetes no more than 12 weeks before entering the study.
Patients were given infusions of either placebo or of one of three regimens of teplizumab. After six months, the treatment was repeated.
After one year, a similar percentage of people in each group -- about 20% -- had better blood sugar control and needed less insulin. But 5% of participants who received teplizumab no longer needed insulin at the end of one year, compared to none of those who received a placebo, Sherry says.
Further researched showed that 40% of patients who received the highest dose of the drug had better beta cell preservation, compared with 28% of those in the placebo group.
Younger patients, especially children ages 8 to 11, experienced the greatest gains in beta cell function, she says.
Get the latest Diabetes newsletter delivered to your inbox!
Your level is currently
If the level is below 70 or you are experiencing symptoms such as shaking, sweating or difficulty thinking, you will need to raise the number immediately. A quick solution is to eat a few pieces of hard candy or 1 tablespoon of sugar or honey. Recheck your numbers again in 15 minutes to see if the number has gone up. If not, repeat the steps above or call your doctor.
People who experience hypoglycemia several times in a week should call their health care provider. It's important to monitor your levels each day so you can make sure your numbers are within the range. If you are pregnant always consult with your health care provider.
Congratulations on taking steps to manage your health.
However, it's important to continue to track your numbers so that you can make lifestyle changes if needed. If you are pregnant always consult with your physician.
Your level is high if this reading was taken before eating. Aim for 70-130 before meals and less than 180 two hours after meals.
Even if your number is high, it's not too late for you to take control of your health and lower your blood sugar.
One of the first steps is to monitor your levels each day. If you are pregnant always consult with your physician.
Thank you for signing up for the WebMD Diabetes Newsletter!
You'll find tips and tricks as well as the latest news and research on Diabetes.
Did You Know Your Lifestyle Choices
Affect Your Blood Sugar?
Use the Blood Glucose Tracker to monitor
how well you manage your blood sugar over time.